Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 7/20 | 0.48 |
| ▸ | CTSK | P43235 | 7/20 | 0.48 |
| ▸ | CTSL | P07711 | 1/20 | 0.48 |
| ▸ | CTSB | P07858 | 1/20 | 0.48 |
| ▸ | BACE1 | P56817 | 8/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29244926 | 1.00 | CTSS (0.48) | CTSSCTSKCTSLCTSBBACE1 | |
| SCHEMBL30968897 | 0.87 | CTSS (0.62) | CTSSCTSKCTSLCTSB | |
| SCHEMBL13583903 | 0.87 | CTSS (0.62) | CTSSCTSKCTSLCTSB | |
| SCHEMBL42634 | 0.87 | CTSS (0.62) | CTSSCTSKCTSLCTSB | |
| SCHEMBL9582823 | 0.87 | CTSS (0.62) | CTSSCTSKCTSLCTSB | |
| SCHEMBL13015865 | 0.86 | PPARG (0.51) | CTSSCTSKCTSLCTSB | |
| SCHEMBL993347 | 0.85 | CTSS (0.49) | CTSSCTSKCTSLCTSB | |
| SCHEMBL13016479 | 0.85 | CTSS (0.63) | CTSSCTSKCTSLCTSBMAPT | |
| SCHEMBL12840932 | 0.85 | CTSS (0.49) | CTSSCTSKCTSLCTSB | |
| SCHEMBL7329532 | 0.82 | BACE1 (0.62) | CTSSCTSKBACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118055923-A | Benzodiazepine derivatives as positive allosteric modulators of the GABAA γ1 receptor | 豪夫迈·罗氏有限公司 | 2024-05-17 | — | — | CN | disclosed |